D S Ettinger

735 total citations
17 papers, 568 citations indexed

About

D S Ettinger is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, D S Ettinger has authored 17 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in D S Ettinger's work include Lung Cancer Research Studies (9 papers), Cancer therapeutics and mechanisms (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). D S Ettinger is often cited by papers focused on Lung Cancer Research Studies (9 papers), Cancer therapeutics and mechanisms (7 papers) and Neuroendocrine Tumor Research Advances (6 papers). D S Ettinger collaborates with scholars based in United States. D S Ettinger's co-authors include Eric K. Rowinsky, Ross C. Donehower, L B Grochow, Martin D. Abeloff, Barbara G. Lubejko, S E Sartorius, J. Eggleston, Seena C. Aisner, Dianne M. Finkelstein and John C. Ruckdeschel and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.

In The Last Decade

D S Ettinger

17 papers receiving 536 citations

Peers

D S Ettinger
G. Dane United Kingdom
Y. Ohe Japan
Linda D. Compton United States
JHM Schellens Netherlands
B. Gérard Belgium
D. Mignard France
J A Sinkule United States
Seiji Doi Japan
D Abigerges France
T Taguchi Japan
G. Dane United Kingdom
D S Ettinger
Citations per year, relative to D S Ettinger D S Ettinger (= 1×) peers G. Dane

Countries citing papers authored by D S Ettinger

Since Specialization
Citations

This map shows the geographic impact of D S Ettinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D S Ettinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D S Ettinger more than expected).

Fields of papers citing papers by D S Ettinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D S Ettinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D S Ettinger. The network helps show where D S Ettinger may publish in the future.

Co-authorship network of co-authors of D S Ettinger

This figure shows the co-authorship network connecting the top 25 collaborators of D S Ettinger. A scholar is included among the top collaborators of D S Ettinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D S Ettinger. D S Ettinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ettinger, D S. (2008). Supportive Care in Cancer Therapy. Humana Press eBooks. 7 indexed citations
2.
3.
Ettinger, D S. (1999). Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer.. PubMed. 9(2 Suppl 1). 148–50. 13 indexed citations
4.
Kalemkerian, Gregory P., et al.. (1998). A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma. Cancer. 83(6). 1102–1108. 27 indexed citations
5.
6.
Donehower, Ross C., et al.. (1994). Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic data. Cancer Chemotherapy and Pharmacology. 33(6). 493–496. 48 indexed citations
7.
Schiller, Joan H., et al.. (1994). Phase II trial of oral etoposide plus cisplatin in extensive stage small cell carcinoma of the lung: an Eastern Cooperative Oncology Group study. European Journal of Cancer. 30(2). 158–161. 9 indexed citations
8.
Rowinsky, Eric K., L B Grochow, D S Ettinger, et al.. (1994). Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks.. PubMed. 54(2). 427–36. 179 indexed citations
9.
Johnson, Douglas H., Andrew T. Turrisi, A. Y. Chang, et al.. (1993). Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.. Journal of Clinical Oncology. 11(5). 879–884. 46 indexed citations
10.
Noe, D A, Eric K. Rowinsky, L B Grochow, et al.. (1990). Phase I and pharmacokinetic study of brequinar sodium (NSC 368390).. PubMed. 50(15). 4595–9. 32 indexed citations
11.
12.
Aisner, Seena C., Dianne M. Finkelstein, D S Ettinger, et al.. (1990). The clinical significance of variant-morphology small-cell carcinoma of the lung.. Journal of Clinical Oncology. 8(3). 402–408. 29 indexed citations
13.
McGuire, W. P., Eric K. Rowinsky, N. Rosenshein, et al.. (1989). Taxol (T): An active new drug in ovarian epithelial cancer (OVCA). Gynecologic Oncology. 32(1). 111–111. 3 indexed citations
14.
Pazdur, Richard, et al.. (1986). Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma.. PubMed. 70(12). 1447–8. 4 indexed citations
15.
Rowinsky, Eric K., et al.. (1986). Phase I and pharmacologic study of hexamethylene bisacetamide in patients with advanced cancer.. Journal of Clinical Oncology. 4(12). 1835–1844. 33 indexed citations
16.
Ettinger, D S, et al.. (1984). Massive bleeding in hypertrophic gastropathy (Menetrier's disease) due to arterio-venous malformation.. PubMed. 15(1). 65–73. 1 indexed citations
17.
Ettinger, D S, Judith E. Karp, Martin D. Abeloff, P. J. Burke, & H. Braine. (1978). Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lung.. PubMed. 62(3). 413–24. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Dane Breakdown of academic impact, for papers by Y. Ohe Breakdown of academic impact, for papers by Linda D. Compton Breakdown of academic impact, for papers by JHM Schellens Breakdown of academic impact, for papers by B. Gérard Breakdown of academic impact, for papers by D. Mignard Breakdown of academic impact, for papers by J A Sinkule Breakdown of academic impact, for papers by Seiji Doi Breakdown of academic impact, for papers by D Abigerges Breakdown of academic impact, for papers by T Taguchi
Rankless by CCL
2026